Evaluation of Vastus Medialis Muscle Inhibition in Indoor Soccer Players with and Without ACL Injury

September 12, 2024 updated by: maria martinez parada, University of Alcala

Evaluation of Muscular Anthrogenic Inhibition of the Vasto Medialis in Indoor Soccer Players with Anterior Cruciate Ligament (ACL) Injury in Comparison with Non-Injured Players: Observational Cohort Study

The Anterior Cruciate Ligament (ACL) is vital for knee stability, and ACL injuries in futsal can lead to long-term issues. Reconstruction surgery may be affected by Anthrogenic Muscle Inhibition (AMI), especially in the vastus medialis muscle. This study aims to compare AMI in futsal players with ACL injuries to those without injuries, focusing on measurement techniques, sports performance, muscle strength, and recovery time. The research involves evaluating 54 players (27 injured and 27 non-injured) at various stages of the season using strength tests and imaging.

Study Overview

Detailed Description

Introduction: The Anterior Cruciate Ligament (ACL) is crucial for knee stability and represents a major challenge in sports such as futsal. ACL injuries can carry a risk of long-term complications. While reconstruction surgery is a common method for recovery, it can be affected by Anthrogenic Muscle Inhibition (AMI), especially in the vastus medialis. Research on AMI in futsal players will be fundamental to improve rehabilitation, functionality, and reduce the risk of relapse.

Objectives: To analyze the changes in the Anthrogenic Muscular Inhibition of the vastus medialis in futsal players with Anterior Cruciate Ligament Injury compared to non-injured players. The specific objectives include evaluating measurement techniques, assessing the impact on sport quality, assessing muscle strength, and examining recovery time.

Methodology: The present study uses an observational cohort design to evaluate AMI in indoor soccer players at different stages of the soccer season, compared to players who suffer ACL injuries during competition. The sample size is 54 subjects, with 27 in each group. Accounting for a 15% loss, the final sample will be 64 subjects (32 in each group). Players will be evaluated for isometric strength by electromyography, strength in extensors, single leg vertical jump test, and ultrasound evaluation. These measurements will be taken for all players in the pre-season, after 4 months, and at the end of the season. For ACL injuries, evaluations will be conducted pre-operation, 4 months post-operation, and at the end of the soccer year.

Key words: Anthrogenic Muscle Inhibition, soccer, Anterior Cruciate Ligament, Rehabilitation.

Study Type

Observational

Enrollment (Estimated)

64

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

The study population consists of futsal players aged 18-45. This includes two groups: (1) players without ACL injuries who serve as a comparison group, and (2) players who have sustained ACL injuries and are undergoing or have undergone ACL reconstruction surgery. The study aims to compare Anthrogenic Muscle Inhibition (AMI) and muscle function between these two groups.

Description

Inclusion Criteria:

  • Age between 18 and 45 years old
  • Playing in the Spanish National League (first or second category) or in the Madrid Futsal Federation in PRIMERA RFFM and PREFERENTE.
  • Both sexes
  • Have been playing futsal for at least 2 years
  • Enrolled in the Madrid Health System
  • Any language

Exclusion Criteria:

  • Operations other than an Anterior Cruciate Ligament injury (Cartilage, Meniscus, Ligaments).
  • Injuries to the knee of the contralateral lower limb. (sprains, fracture)
  • Muscle injuries or conditions in the affected or contralateral limb for less than 2 months (sprains, tibial periostitis, tendinopathies, tears).
  • Any infection must be reported after the intervention and will be excluded from the study.
  • Players will not be allowed to play any kind of team sport other than Futsal in an official way during this season.
  • Players may not have any cardiovascular or respiratory pathology that would affect the study.
  • Players who have already undergone an Anterior Cruciate Ligament rupture in previous years will not be considered.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
UNINJURED PLAYERS
Players will be evaluated for isometric strength by electromyography, extensor strength, single leg vertical jump test and ultrasound evaluation, all of which will be measured on all players in the preseason, at 4 months and at the end of the season.
This study involves evaluating Anthrogenic Muscle Inhibition (AMI) of the vastus medialis muscle in futsal players. The intervention includes assessments of muscle strength, AMI using electromyography, ultrasound evaluation, and single-leg vertical jump tests. These evaluations are conducted at different stages throughout the season: pre-season, 4 months in, and at the end of the season. The goal is to compare AMI levels and muscle function between players with ACL injuries and those without.
Other Names:
  • Vastus Medialis AMI Assessment
  • Isometric Strength Evaluation Protocol
INJURED PLAYERS
As for futsal players with ACL injuries, isometric strength is evaluated in pre-operation, at 4 months and at the end of the soccer year by electromyography, extensor strength, single-leg vertical jump test and ultrasound evaluation.
This study involves evaluating Anthrogenic Muscle Inhibition (AMI) of the vastus medialis muscle in futsal players. The intervention includes assessments of muscle strength, AMI using electromyography, ultrasound evaluation, and single-leg vertical jump tests. These evaluations are conducted at different stages throughout the season: pre-season, 4 months in, and at the end of the season. The goal is to compare AMI levels and muscle function between players with ACL injuries and those without.
Other Names:
  • Vastus Medialis AMI Assessment
  • Isometric Strength Evaluation Protocol

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anthrogenic Muscle Inhibition (AMI) of Vastus Medialis
Time Frame: First 4 weeks (28 days), 4 months (120 days) after the start of the season, and the last 4 months (120 days) of the season. 3 months (90 days) before the operation, 4 months (120 days) after the operation, and the last 4 months (120 days) of the season
This measure evaluates the level of Anthrogenic Muscle Inhibition (AMI) in the vastus medialis muscle. Assessment Tool: Electromyography and Ultrasound Unit of Measure: Percentage (%)
First 4 weeks (28 days), 4 months (120 days) after the start of the season, and the last 4 months (120 days) of the season. 3 months (90 days) before the operation, 4 months (120 days) after the operation, and the last 4 months (120 days) of the season

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
isometric extension maximum knee with traction
Time Frame: First 4 weeks (28 days), 4 months (120 days) after the start of the season, and the last 4 months (120 days) of the season. 3 months (90 days) before the operation, 4 months (120 days) after the operation, and the last 4 months (120 days) of the season
this test is used to obtain strength maximum knee extension. For To be able to measure, a cell of strain gauge load fixed to the stretcher where the test will be performed with the knee fixed at 90º. It will be carried out in the two legs, noting which of them is the dominant. Newton (N)
First 4 weeks (28 days), 4 months (120 days) after the start of the season, and the last 4 months (120 days) of the season. 3 months (90 days) before the operation, 4 months (120 days) after the operation, and the last 4 months (120 days) of the season
The Single Leg Vertical Jump exercise
Time Frame: First 4 weeks (28 days), 4 months (120 days) after the start of the season, and the last 4 months (120 days) of the season. 3 months (90 days) before the operation, 4 months (120 days) after the operation, and the last 4 months (120 days) of the season
It is a test used to being able to know the strength, power and capacity that the muscle has where the participant performs a vertical jump with a single leg, in this case it will be 3 times with one and 3 times with the leg contralateral. CM
First 4 weeks (28 days), 4 months (120 days) after the start of the season, and the last 4 months (120 days) of the season. 3 months (90 days) before the operation, 4 months (120 days) after the operation, and the last 4 months (120 days) of the season
assessment surface electromyography
Time Frame: First 4 weeks (28 days), 4 months (120 days) after the start of the season, and the last 4 months (120 days) of the season. 3 months (90 days) before the operation, 4 months (120 days) after the operation, and the last 4 months (120 days) of the season
the function neuromuscular and detect imbalances in muscle activation. HE surface electrodes will be used adhesives to the vastus medialis. To obtain electromyographic tracings patient will perform a contraction maximum isometric 6 seconds duration. microvolts
First 4 weeks (28 days), 4 months (120 days) after the start of the season, and the last 4 months (120 days) of the season. 3 months (90 days) before the operation, 4 months (120 days) after the operation, and the last 4 months (120 days) of the season

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2025

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

August 31, 2026

Study Registration Dates

First Submitted

August 21, 2024

First Submitted That Met QC Criteria

September 12, 2024

First Posted (Estimated)

September 19, 2024

Study Record Updates

Last Update Posted (Estimated)

September 19, 2024

Last Update Submitted That Met QC Criteria

September 12, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Injuries

Clinical Trials on Anthrogenic Muscle Inhibition (AMI) Assessment Protocol

Subscribe